Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01286324 · ClinicalTrials.gov registry record · Phase 2
Chamomile for Chronic Primary Insomnia
A Phase 2 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
NCT01286324 is a Phase 2 study that has completed, run by University of Michigan. The registered enrollment target is 34 participants.
The verdict
NCT01286324, a Phase 2 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if an herb called chamomile can help to treat insomnia (difficulty in going to sleep or getting enough sleep) by increasing the amount of time that you sleep and/or improving the quality of your sleep. The study will also be looking at the effect of chamomile on day time fatigue and functioning.
Interventions
- DRUG Placebo Tablet
- DIETARY_SUPPLEMENT Chamomile High Grade Extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01286324
The ClinicalTrials.gov registry entry for NCT01286324 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Tablet is the first listed.
NCT01286324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01286324 about?
NCT01286324 is a clinical study titled "Chamomile for Chronic Primary Insomnia". The purpose of this study is to determine if an herb called chamomile can help to treat insomnia (difficulty in going to sleep or getting enough sleep) by increasing the amount of time that you sleep and/or improving the quality of your sleep. The study will also be looking at the effect of chamomil...
What is the current status of trial NCT01286324?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2008-07. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01286324?
The interventions under investigation include: Placebo Tablet (DRUG), Chamomile High Grade Extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01286324?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.